Tuberculosis
(TB) during pregnancy in HIV-infected women is associated with poor maternal
and infant outcomes. There are limited data on TB prevalence, optimal TB
screening, and performance of rapid diagnostics in pregnant HIV-infected women.
Between
July 2013 and July 2014, we enrolled 306 women. Among 288 women with a valid
sputum culture result, 54% were on antiretroviral treatment, median CD4 cell
count was 437 cell/mm (IQR 342-565), and prevalence of culture-confirmed
pulmonary TB was 2.4% (CI 1.0-4.9%). Cough >2 weeks (p=0.04) and positive
TST (>5mm, p=0.03) were associated with pulmonary TB. Women with TB were
23-fold (95% CI 4.4-116.6) more likely to report a household member with TB
symptoms (p=0.002). WHO symptom screen (43%), AFB smear (0%), Xpert (43%) and
LAM (0%) had low sensitivity but high specificity (81%, 99%, 99% and 95%,
respectively) for pulmonary TB.
HIV-infected
pregnant women had appreciable prevalence of pulmonary TB despite modest
immunosuppression. Current TB screening and diagnostic tools perform poorly in
pregnant HIV-infected women. Adapted TB screening tools that include household
member TB symptoms may be useful in this population.
- 1Departments of 1Medicine, 2Epidemiology, 3Pediatrics, 4Global Health, 5Biostatistics, 6Firland Northwest Tuberculosis Center, University of Washington, Seattle, WA, USA, 7Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA, Departments of 8Research and Programs, 9Reproductive Health, Kenyatta National Hospital, Nairobi, Kenya.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment